Securities code: Pharmaron Beijing Co.Ltd(300759) securities abbreviation: Pharmaron Beijing Co.Ltd(300759) Announcement No.: 2022021 Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd
Announcement on the proposed employment of domestic financial and internal control audit institutions in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Description of domestic financial and internal control audit institutions to be employed in 2022
Ernst & Young Huaming Certified Public Accountants (special general partnership) (hereinafter referred to as “Ernst & Young Huaming”) is an accounting firm with the qualification to engage in securities related business approved by the Ministry of Finance and China Securities Regulatory Commission. An Yonghua Ming issued the 2021 domestic financial statement audit report and internal control audit report for KANGLONG Huacheng (Beijing) new drug Technology Co., Ltd. (hereinafter referred to as “the company” or “the company”). During the audit, an Yonghua Ming fully possessed the independence, professional competence and investor protection ability, and successfully completed the work related to the company’s annual audit in 2021.
In order to maintain the continuity of audit work, the company plans to renew the employment of Ernst & Young Huaming as the domestic financial and internal control audit institution of the company in 2022 for one year after deliberation and approval of the 10th meeting of the audit committee of the second board of directors, the 18th meeting of the second board of directors and the 14th meeting of the second board of supervisors. The domestic financial audit fee of the company in 2021 is RMB 2.2 million and the internal control audit fee is RMB 460000. The pricing principle of audit fees in 2022 is consistent with that in 2021, which is mainly based on the responsibility of professional services and the degree of professional technology investment, and comprehensively considering the experience and level of employees involved in the work, the corresponding charging rate and the working hours invested. The relevant annual audit fees will be submitted by the board of directors of the company to the general meeting of shareholders to authorize the management to determine according to the specific workload and market price level of the audit in 2022.
1. Basic information
Ernst & Young Huaming was established in September 1992 and completed the localization transformation in August 2012, from a Sino foreign cooperative limited liability firm to a special general partnership firm. Ernst & Young Huaming is headquartered in Beijing and its registered address is room 01-12, 17th floor, Ernst & Young building, Oriental Plaza, No. 1, East Chang’an Street, Dongcheng District, Beijing. By the end of 2021, it has 203 partners, and the chief partner is Mr. Mao Anning. An Yonghua Ming has always paid attention to talent training. By the end of 2021, it has 1604 certified public accountants, including more than 1300 certified public accountants with experience in securities related business services, and more than 400 certified public accountants who have signed the audit report of securities service business. The total business income of Ernst & Young Huaming in 2020 was RMB 4.76 billion, including audit business income of RMB 4.589 billion and securities business income of RMB 2.146 billion. In 2020, there were 100 annual report audit clients of A-share listed companies, with a total charge of RMB 824 million. The main industries of these listed companies involve manufacturing, finance, wholesale and retail, information transmission, software and information technology services, real estate, etc. The company has 3 audit clients of Listed Companies in the same industry.
2. Investor protection ability
Ernst & Young Huaming has good investor protection ability and has purchased professional insurance in accordance with relevant laws and regulations, covering Beijing head office and all branches. The sum of the accrued occupational risk fund and the purchased occupational insurance cumulative compensation limit exceeds 200 million yuan. Ernst & Young Huaming has not borne any civil liability due to civil litigation related to practice in recent three years.
3. Integrity record
Ernst & Young Huaming and its employees have not been subject to any criminal punishment or administrative punishment due to their professional behavior in recent three years, as well as the self-discipline supervision measures and disciplinary sanctions of self-discipline organizations such as stock exchanges and industry associations. It has twice received the decision of warning letter measures issued by the securities regulatory authority, involving 13 employees. The aforesaid decision to issue a warning letter is a supervisory and administrative measure, not an administrative penalty. According to the provisions of relevant laws and regulations, the supervision and management measures will not affect an Yonghua ming to continue to undertake or perform securities service business and other businesses.
1. Basic information
Ms. Yang Jinglu, the project partner and the first signing certified public accountant, became a certified public accountant in 2005, began to engage in the audit of Listed Companies in 2004, began to practice at Ernst & Young Huaming in 2002, and began to provide audit services for the company in 2019; In the past three years, the annual reports and internal control audits of three listed companies have been signed or reviewed, involving research and experimental development, pharmaceutical manufacturing and wholesale industry.
Ms. Zhou Hua, the reviewer of project quality control, became a certified public accountant in 2007, began to engage in the audit of Listed Companies in 2005, began to practice at Ernst & Young Huaming in 2002, and began to provide audit services for the company in 2020; In the past three years, the annual reports and internal control audits of five listed companies have been signed or reviewed, involving industries such as research and experimental development, leasing industry, agricultural and sideline food processing industry and manufacturing industry.
Ms. Zhang Ying, the second signing certified public accountant of the project, became a certified public accountant in 2009, began to engage in the audit of Listed Companies in 2006, began to practice at Ernst & Young Huaming in 2006, and began to provide audit services for the company in 2020; In the past three years, we have signed or reviewed the annual reports and internal control audits of two listed companies, involving research and experimental development and civil engineering construction.
2. Integrity record
In the past three years, the above project partners, signed certified public accountants and project quality control reviewers have not been subject to criminal punishment for their professional behavior, administrative punishment, supervision and management measures of the CSRC, its dispatched offices and industry competent departments, or self-discipline supervision measures and disciplinary sanctions of self-discipline organizations such as securities exchanges and industry associations.
3. Independence
Ernst & Young Huaming and the above project partners, signing certified public accountants and project quality control reviewers do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
4. Audit fees
The domestic financial audit fee of the company in 2021 is RMB 2.2 million, and the internal control audit fee is RMB
RMB 460000. The pricing principle of audit fees in 2022 is consistent with that in 2021, which is mainly based on the responsibility of professional services and the degree of professional technology investment, and comprehensively considering the experience and level of employees involved in the work, the corresponding charging rate and the working hours invested. The relevant annual audit fees will be submitted by the board of directors of the company to the general meeting of shareholders to authorize the management to determine according to the specific workload and market price level of the audit in 2022.
4、 Procedures to be performed by domestic financial and internal control audit institutions in 2022
1. The company held the 10th meeting of the audit committee of the second board of directors on March 25, 2022. The meeting deliberated and adopted the proposal on the company’s employment of domestic financial and internal control audit institutions in 2022.
The members of the audit committee believe that the Institute has full independence, professional competence and investor protection ability, is in good faith and can meet the company’s requirements for audit institutions. Agree to renew the appointment of Ernst & Young Huaming as the domestic financial and internal control audit institution of the company in 2022, and agree to submit this matter to the board of directors of the company for deliberation.
2. The company held the 18th meeting of the second board of directors on March 25, 2022. The meeting deliberated and approved the proposal on the company’s employment of domestic financial and internal control audit institution in 2022, and plans to continue to employ an Yonghua Ming as the company’s domestic financial and internal control audit institution in 2022.
3. Prior approval opinions and independent opinions of independent directors
Prior approval:
Ernst & Young Huaming Certified Public Accountants (special general partnership) has the business qualification related to securities and futures, and has sufficient independence, professional competence, investor protection ability and good integrity record. In the course of practice, the Institute adheres to the principle of independent audit, can objectively, fairly and fairly reflect the company’s financial situation and internal control, and earnestly perform the responsibilities of the audit institution, which is conducive to improving the quality of audit work of listed companies and protecting the interests of listed companies and other shareholders, especially the interests of small and medium-sized shareholders. Therefore, we agree to renew the appointment of Ernst & Young Huaming Certified Public Accountants (special general partnership) as the domestic financial and internal control audit institution of the company in 2022, and agree to submit the matter to the 18th meeting of the second board of directors for deliberation.
Independent opinion:
Ernst & Young Huaming Certified Public Accountants (special general partnership) has business qualification related to securities and futures. The Institute has issued the domestic financial statement audit report and internal control audit report for the company in 2021, and has completed the relevant financial audit and internal control audit of the company in 2021. In the audit process, the Institute is fully independent, professional competent, investor protection and good integrity record. In the course of practice, the Institute adheres to the principle of independent audit, can objectively, fairly and fairly reflect the company’s financial and internal control status, and earnestly perform the responsibilities of the audit institution, which is conducive to improving the quality of audit work of listed companies and protecting the interests of listed companies and shareholders, especially the interests of small and medium-sized shareholders. The company’s review procedures for the appointment of domestic financial and internal control audit institutions in 2022 comply with the relevant provisions of relevant laws and regulations. Therefore, we agree to renew the appointment of Ernst & Young Huaming Certified Public Accountants (special general partnership) as the company’s domestic financial and internal control audit institution in 2022, and agree to submit the matter to the general meeting of shareholders for review.
4. The company held the 14th meeting of the second board of supervisors on March 25, 2022. The meeting deliberated and approved the proposal on the company’s employment of domestic financial and internal control audit institution in 2022, and agreed to renew the employment of an Yonghua Ming as the company’s domestic financial and internal control audit institution in 2022.
5. The renewal of the accounting firm needs to be submitted to the general meeting of shareholders for deliberation.
5、 Documents for future reference
1. Resolutions of the 18th meeting of the second board of directors;
2. Resolutions of the 14th meeting of the second board of supervisors;
3. Resolutions of the 10th meeting of the audit committee of the second board of directors;
4. Independent opinions of independent directors on matters related to the 18th meeting of the second board of directors;
5. Prior approval opinions of independent directors on matters related to the 18th meeting of the second board of directors;
6. The business license of the accounting firm to be employed, the information and contact information of the main person in charge and the contact person of the regulatory business, and the identity certificate, practice license and contact information of the certified public accountant to be responsible for the specific audit business; 7. Other documents required by Shenzhen Stock Exchange.
It is hereby announced.
Pharmaron Beijing Co.Ltd(300759) (Beijing) new drug Technology Co., Ltd. board of directors March 28, 2022
